Thursday, February 23, 2006 8:39:18 PM
Amylin released data that showed its pramlintide helped obese patients lose weight. In a 16-week trial, 408 patients lost an average of 8.4 pounds to 13.4 pounds (the average loss is 6.2 pounds) and in general experienced progressive weight loss during the 16 weeks. In the weight-loss arena this is very good data and let me remind you, Amylin's two new diabetes drugs are the only diabetes treatments on the market that induce weightloss -- other treatments create weight gain.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
